|
Author (publication year) (citation) | Study design | # of patients | Sedation goal | Dex dose | Dex intervention time | Control |
|
Jaionen et al. [25] | Double blind, parallel-group, randomized controlled trial | 80 | Unspecified | Loading dose 50 ng/kg/min for 30 mins and then maintained at 7 ng/kg/min | 30 mins before initiation of surgical anesthesia—end of surgery | Saline placebo |
|
Corbett et al. [23] | Prospective, randomized study | 89 | RSS of 5 for the first 2 h postoperative, followed by a score of 3 to 4 during intubation | Loading dose of 1 μg/kg induction and then maintained by 0.4 μg/kg/h | ICU admission—1 hr postextubation | Propofol: 0.2 to 0.7 μg/kg/h |
|
Shehabi et al. [20] | Randomized, double-blinded controlled trial | 299 | MAAS 2–4 | 0.1 to 0.7 μg/kg/h | ICU admission—extubation/leaving the ICU/48 h maximum | Morphine: 10 to 70 μg/kg/h |
|
Herr et al. [24] | Randomized, open label study | 295 | RSS ≥3 during assisted ventilation and ≥2 after extubation | Loading dose of 1.0 μg/kg and then maintained by 0.2 to 0.7 μg/kg/h | Sternal closure—24 h in the ICU | Propofol: unspecified dose |
|
Ren et al. [22] | Randomized controlled trial | 162 | Unspecified | 0.2–0.5 μg/kg/h | Following the first vascular anastomosis grafting—12 h in the CICU | Saline placebo |
|
Soltani et al.[27] | Randomized, blinded clinical trial | 76 | BIS 40–60 | 0.5 μg/kg/h | Surgical induction—transfer to CICU | Saline placebo |
|